We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

99 hedge funds and large institutions have $1.08B invested in Agios Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 12

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

34% more capital invested

Capital invested by funds: $804M → $1.08B (+$277M)

34% more funds holding

Funds holding: 74 → 99 (+25)

61% less call options, than puts

Call options by funds: $569K | Put options by funds: $1.46M

Holders
99
Holders Change
+25
Holders Change %
+33.78%
% of All Funds
2.85%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.17%
New
37
Increased
37
Reduced
20
Closed
12
Calls
$569K
Puts
$1.46M
Net Calls
-$888K
Net Calls Change
-$888K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$59.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$41.6M
3
Capital World Investors
Capital World Investors
California
+$32.5M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$31.1M
5
BB
BB Biotech
Switzerland
+$20.6M

Top Sellers

1
FV2GP
Flagship Ventures 2007 General Partner
Massachusetts
-$78.7M
2
TRV
Third Rock Ventures
Massachusetts
-$68M
3
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$8.14M
4
OIM
Oracle Investment Management
Connecticut
-$3.92M
5
Jennison Associates
Jennison Associates
New York
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
Artisan Partners
26
Artisan Partners
Wisconsin
$7.28M +$6.48M +158,940 New
BIT
27
BlackRock Institutional Trust
California
$6.95M +$3.08M +75,458 +99%
BA
28
BlackRock Advisors
Delaware
$6.81M +$2.94M +72,101 +94%
JP Morgan Chase
29
JP Morgan Chase
New York
$6.6M -$499K -12,230 -8%
QF
30
QVT Financial
New York
$5.92M +$5.26M +129,100 New
OM
31
Opaleye Management
Massachusetts
$5.27M +$4.69M +115,000 New
Northern Trust
32
Northern Trust
Illinois
$4.57M +$418K +10,244 +11%
Deutsche Bank
33
Deutsche Bank
Germany
$4.18M +$3.37M +82,738 +975%
KCM
34
Kornitzer Capital Management
Kansas
$3.82M -$652K -16,000 -16%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$3.58M +$1.21M +29,643 +61%
GC
36
Guggenheim Capital
Illinois
$3.36M +$2.99M +73,275 New
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$3.06M +$2.73M +66,853 New
BlackRock
38
BlackRock
New York
$2.89M +$2.56M +62,814 +32,212%
Axa
39
Axa
France
$2.88M – – –
Geode Capital Management
40
Geode Capital Management
Massachusetts
$2.72M +$840K +20,614 +53%
MSA
41
Mason Street Advisors
Wisconsin
$2.46M – – –
TCIM
42
TIAA CREF Investment Management
New York
$2.33M +$928K +22,775 +81%
Point72 Asset Management
43
Point72 Asset Management
Connecticut
$2.11M +$1.88M +46,100 New
BIM
44
BlackRock Investment Management
Delaware
$2.1M +$1.06M +25,996 +132%
BG
45
BlackRock Group
United Kingdom
$2.03M +$880K +21,600 +95%
EI
46
EAM Investors
California
$1.88M +$394K +9,664 +31%
Ameriprise
47
Ameriprise
Minnesota
$1.71M +$410K +10,052 +37%
TG
48
TCW Group
California
$1.63M -$122K -2,993 -8%
SIM
49
Spark Investment Management
New York
$1.43M +$1.28M +31,300 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.43M +$1.17M +28,730 +1,163%
1
2
3 4 5

AGIO Hedge Fund Activity: Q2 2014 in Review

99 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q2 2014, worth a combined $1.08B — up 34% from $804M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new AGIO positions and 12 closed out — a net gain of 25 holders — while 37 added to existing stakes and 20 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $59.1M. The largest seller was Flagship Ventures 2007 General Partner, cutting an estimated $78.7M.

  • 99 institutional investors held Agios Pharmaceuticals (AGIO) as of Q2 2014, up from 74 in Q1 2014.
  • Funds reported $1.08B of Agios Pharmaceuticals stock for Q2 2014, up 34% quarter-over-quarter.
  • 37 funds opened new Agios Pharmaceuticals positions in Q2 2014 and 12 closed out, a net change of +25 holders.
  • The largest Agios Pharmaceuticals buyer in Q2 2014 was Fidelity Investments, an estimated $59.1M added.
  • The largest Agios Pharmaceuticals seller in Q2 2014 was Flagship Ventures 2007 General Partner, an estimated $78.7M sold.

Based on aggregated 13F filings for Q2 2014.